CorMedix Inc. Common Stock

CRMD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$7.55+0.27%

2026-08-03

Financials

Valuation Metrics

CorMedix Inc. Common Stock's Market Cap is $592M. At end of 2025 it was $838M. Ranked #2720 of 3,111 in US market (top 87%), #1163 of 1,445 on NASDAQ (top 80%), #215 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 80%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$592M	US#2,720/3,111 Sec#215/269
Revenue	$400M	US#2,452/3,111 Sec#89/269
Net Income	$181M	US#1,313/3,111 Sec#47/269
Total Assets	$816M	US#2,541/3,111 Sec#109/269
Net Assets	$437M	US#2,357/3,111 Sec#128/269
Value
P/E	3.27x	US#19/3,111 Sec#3/269
P/B	1.36x	US#690/3,111 Sec#33/269
PEG	0.04x	US#86/3,111 Sec#7/269
P/S	1.48x	US#978/3,111 Sec#19/269
EV/EBITDA	2.63x	US#35/3,111 Sec#4/269
FCF Yield	33.16%	US#58/3,111 Sec#3/269
Profitability
ROE	41.42%	US#154/3,111 Sec#16/269
ROA	22.19%	US#70/3,111 Sec#16/269
Op. Margin	48.41%	US#121/3,111 Sec#5/269
Revenue Growth	226.05%	US#66/3,111 Sec#20/269
Earnings Growth	86.98%	US#387/3,111 Sec#16/269
Financial Health
Debt Ratio	86.62%	US#949/3,111 Sec#162/269
Total Debt	$145M	US#2,320/3,111 Sec#105/269
FCF	$196M	US#1,374/3,111 Sec#47/269
Cash	$178M	US#1,808/3,111 Sec#124/269
Current Ratio	2.98x	US#821/3,111 Sec#197/269
Net Debt/EBITDA	-0.16x	US#551/3,111 Sec#30/269
Performance
1Y Return	-35.14%	US#2,802/3,111 Sec#232/269
1M Return	-13.71%	US#2,542/3,111 Sec#191/269
From 52W High	-49.53%	US#2,736/3,111 Sec#217/269
1Y MDD	-62.26%	US#2,775/3,111 Sec#222/269
Trading
Volume	813,415 shares	US#1,842/3,111 Sec#179/269
Trading Value	$6M	US#2,657/3,111 Sec#222/269